A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review

Eur J Dermatol. 2017 Feb 1;27(1):88-89. doi: 10.1684/ejd.2016.2883.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / metabolism*
  • Drug Eruptions / pathology
  • Humans
  • Interleukin-17 / analysis
  • Interleukin-23 / analysis*
  • Interleukin-23 / biosynthesis
  • Male
  • Middle Aged
  • Parakeratosis / chemically induced
  • Parakeratosis / pathology
  • Penicillanic Acid / adverse effects
  • Penicillanic Acid / analogs & derivatives*
  • Piperacillin / adverse effects
  • Piperacillin, Tazobactam Drug Combination

Substances

  • Anti-Bacterial Agents
  • Interleukin-17
  • Interleukin-23
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Piperacillin